Abstract: Embodiments herein are directed to a hemostatic medical device including an applicator having a receptacle with an output end and a moveable piston configured to move at least partially within the receptacle, and a plurality of liquid expandable articles disposed within the applicator, wherein each liquid expandable article has a volume greater than 50 mm3.

Abstract: A transparent EMI shielding/absorbing film is provided. The transparent EMI shielding/absorbing film includes a transparent substrate having a top surface on which a pattern having a plurality of engraved grooves is disposed, a conductive layer disposed in the grooves, and a conductive nanowire layer disposed on the top surface of the transparent substrate and electrically connected with the conductive layer.

Abstract: The disclosure is directed to a method of accessing a radio network, a server and a base station of a radio access network, and a non-transitory computer-readable storage medium thereof. In an embodiment, the method includes the following steps: initializing one or more base stations, transmitting the information of a control function to the server, transmitting commands with control parameter configuration to the one or more base stations. The one or more base stations separate the control function and data function for communication protocols.

Abstract: Provided is a point of interest management system. The point of interest management system includes a point of stay extraction unit configured to extract a point of stay based on environment collection information received from a smart device, and a point of interest extraction unit configured to calculate a similarity of the point of stay by comparing environmental information of the point of stay with environmental information of a pre-stored point of interest and determine whether to update the point of interest according to a comparison result between the similarity of the point of stay and a reference similarity.

Abstract: Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), neoplasms and neoplasm-related conditions, and for detecting doppel expression in a subject. Related compositions and methods also are described.

Abstract: The present disclosure provides a pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis, including: an effective amount of an extract of a plant belonging to Rutaceae as an effective ingredient for treating or alleviating the autoimmune disease and/or complication thereof and/or nephritis, wherein the autoimmune disease is selected from a group consisting of lupus erythematosus, psoriasis, psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, Crohn's disease and ulcerative colitis (UC).

Abstract: Disclosed is a self-locked laser system, including: a semiconductor substrate; a laser diode including a first semiconductor part disposed on the semiconductor substrate, and which generates an optical signal; an unidirectional Whispery Gallery Mode (WGM) resonator including a second semiconductor part disposed on the semiconductor substrate; and a structure emitting an optical signal self-locked by the optical signal of the laser diode, in which the laser diode and the resonator are optically coupled on the semiconductor substrate.

Abstract: Disclosed are polymer nanofiber sensors for detecting gas, which generates visible color change although a specific gas having a concentration of less than 1 ppm is exposed to the sensor in a short time, in which it is impossible to detect the gas using existing colorimetric sensors, through securing high surface area and porosity, and a method of the same.

Abstract: An apparatus includes a first predistorter configured to calculate a first predistortion parameter and configured to distort an input signal using the first predistortion parameter to output a first distortion signal, a second predistorter configured to calculate a second predistortion parameter and configured to distort the first distortion signal using the second predistortion parameter to output a second distortion signal, a power supply configured to receive the first distortion signal to generate a first envelope signal, and configured to limit a bandwidth of the first envelope signal to obtain a second envelope signal to supply a source voltage, and a power amplifier configured to receive the source voltage and to output an output signal obtained by amplifying the second distortion signal.

Abstract: To provide a method capable of easily compensating waveform distortion due to a non-linear effect caused by a complicated electric circuit, and a device for implementing the method. Provided are a method capable of effectively compensating signal degradation such as waveform distortion due to a nonlinear effect caused by an optical fiber that is an optical transfer path using an optical phase conjugate signal pair at the time of optical up-conversion or down-conversion, and a device capable of implementing the method. This emission device 25 includes an optical modulator 11, a signal source 13, an optical fiber 15, a multiplexing unit 17, a multiplexing local signal source 19, an optical detector 12, and a transmission antenna 23.

Abstract: The present invention provides stably crosslinked insulinotropic polypeptides having superior and unexpected benefits in the treatment of conditions involving abnormal glucose homeostasis, e.g., type 2 diabetes and conditions relating to type 2 diabetes. Such benefits include, but are not limited to, extended polypeptide half-life, enhanced alpha-helicity, improved thermal stability and protease resistance, increased functional activity and pharmacologic properties, improved bioavailability when administered by any route, and improved bioavailability and gastrointestinal absorption when delivered orally, as compared to the corresponding unmodified polypeptides. The invention also provides compositions for administering the polypeptides of the invention, as well as methods for preparing and evaluating the polypeptides of the invention.

Abstract: Solar cells in accordance with a number of embodiments of the invention are encapsulated by a material that can render the front contacts of the solar cells effectively invisible at certain angles of incidence. Front contacts of a solar cell provide a way for current to escape from the solar cell. However, these front contacts cover portions of the photoabsorbing substrate, blocking incident light that could otherwise be utilized by the photoabsorbing substrate for electrical power generation. By encapsulating the solar cell and using encapsulated volumes above the front contact that define interfaces, light reaching the interface can be refracted due to the different refractive indices of the two media. Depending on the refractive index ratio, total internal reflection can occur at certain angles of incidence. Totally internally reflected light can be redirected away from the front contacts and onto the photoabsorbing substrate, thereby reducing optical waste.

Abstract: Provided is a method for manufacturing a base material powder having a carbon nanocoating layer, the method including adding a polycyclic aromatic hydrocarbon to a base material powder, heating the mixture to a temperature that is higher than or equal to the boiling point of the polycyclic aromatic hydrocarbon and is lower than or equal to the relevant boiling point temperature +300° C., and that is higher than or equal to the thermal decomposition temperature of the polycyclic aromatic hydrocarbon, and thereby coating the surface of the base material powder with a layer of carbon having a thickness of 0.1 nm to 10 nm.

Abstract: A configuration and measurement method for performing a full-duplex communication and a base station (BS) using the same is disclosed. In an embodiment, a base station selects a transmitting user equipment (UE) among one or more transmitting UEs and a receiving UE among one or more receiving UEs to form a transmit-receive (TX-RX) UE pair of one or more TX-RX UE pairs for performing the full-duplex communication, based on a first channel strength between the BS and the transmitting UE, a second channel strength between the BS and the receiving UE, and a third channel strength between the transmitting UE and the receiving UE. And the BS transmits an informing message of the one or more TX-RX UE pairs for triggering the channel measurement and the information fed back.

Abstract: Robotic systems for supporting a human in stationary and/or mobile applications and related methods of operation are described.

Abstract: Provided is a processor system including a first processor driven by a first driving voltage and a first driving clock, a second processor driven by a second driving voltage and a second driving clock and configured to perform an identical task to the first processor, and a defect detector configured to perform level synchronization or clock domain synchronization on a first output signal provided from the first processor and a second output signal provided from the second processor to compare the first and second output signals, wherein the first and second driving voltages are respectively provided from mutually independent power supply sources and the first and second driving clocks are respectively provided from mutually independent clock generators.

Abstract: From experiments using colitis model mice, the present inventors discovered that siRNAs that suppress the CHST15 gene expression have a therapeutic effect against Crohn's disease or ulcerative colitis. Specifically, the present inventors discovered that the siRNAs which suppress the CHST15 gene expression can serve as an agent for promoting mucosal healing, in particular, an agent for treating Crohn's disease or ulcerative colitis, and thereby completed the present invention.

Abstract: The present disclosure relates to a passive safety system which uses a heat exchanger together with a thermoelectric element, and a nuclear power plant comprising the same. Disclosed are a passive safety system and a nuclear power plant comprising the same, the passive safety system comprising: a heat exchanger; a thermoelectric element; and a fan unit. The heat exchanger is formed at a space inside or outside a sealed housing, and in the heat exchanger, atmosphere is introduced and heat exchange is carried out in order to lower the pressure or temperature of the atmosphere inside the housing if an accident occurs in a reactor coolant system or a secondary system disposed inside the housing.

Abstract: The present invention relates to novel pyrimido-diazepinone compounds, methods of modulating protein kinases, including MPS1 (TTK), ERK5 (BMK1, MAPK7), polo kinase 1, 2, 3, or 4, Ack1, Ack2, Abl, DCAMKL1, ABL1, Abl mutants, DCAMKL2, ARK5, BRK, MKNK2, FGFR4, TNK1, PLK1, ULK2, PLK4, PRKD1, PRKD2, PRKD3, ROS1, RPS6KA6, TAOK1, TAOK3, TNK2, Bcr-Abl, GAK, cSrc, TPR-Met, Tie2, MET, FGFR3, Aurora, Axl, Bmx, BTK, c-kit, CHK2, Flt3, MST2, p70S6K, PDGFR, PKB, PKC, Raf, ROCK-H, Rsk1, SGK, TrkA, TrkB and TrkC, and the use of such compounds in the treatment of various diseases, disorders or conditions.

Abstract: In an embodiment, a base station (BS) receives one or more first data transmitting from at least one of one or more transmitting user equipments (UEs). The BS transmits a message including assistance parameters for performing a full-duplex data transmission, to at least one of one or more receiving UEs, wherein the parameters are associated with information of reducing an interference from the at least one of the transmitting UEs. And, the BS transmits one or more second data including the one or more first data to the at least one of the receiving UEs. Wherein, the receiving UEs and the transmitting UEs respectively include at least one of: one or more half-duplex UEs, one or more full-duplex UEs, or any combination of two or more of the half-duplex UEs and the full-duplex UEs.